The outlook of companies tied to flagship drugs like Viagra presents a challenging investment picture. While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the patent expiration in here key markets has introduced significant uncertainty . Investors are now grappling with the effect of generi